Action INDOCO INDOCO REMEDIES LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Indoco Remedies Limited

Actions

INDOCO

INE873D01024

Marché Fermé - NSE India S.E.
Autres places de cotation
 13:40:29 16/07/2024 		Varia. 5j. Varia. 1 janv.
339,7 INR +2,55 % Graphique intraday de Indoco Remedies Limited -0,18 % -14,04 %
06/06 Indoco Remedies obtient l'approbation provisoire de la FDA américaine pour un médicament générique contre le diabète de type 2 MT
06/06 Indoco Remedies reçoit l'approbation provisoire de l'USFDA pour les comprimés de canagliflozine et de chlorhydrate de metformine CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Indoco Remedies Limited Receives Demand of INR 1.346 Million from Office of the Joint Commissioner, State Tax, Circle ­ A, Zone II, Jaipur
Indoco Remedies Limited Receives Notice from the Goods and Service Tax Authority: Assistant Commissioner of State Tax Raipur- 9, Raipur Division-2, Chhattisgarh
Indoco Remedies Faces Potential GST Demand of INR 0.282 Million from Office of the Joint Commissioner State Tax Special Circle , Ranchi
Indoco Remedies Gets US FDA's Tentative Approval for Generic Type 2 Diabetes Drug
Indoco Remedies Receives Tentative ANDA Approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules
Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules
Indoco Remedies Limited Receives Show Cause Notice from Office of the Joint Commissioner of State Tax Patna Special Circle, Patna Bihar
Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division
Indoco Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Indoco Remedies Limited Receives Show Cause Notice Received from the Goods and Service Tax Authority
Indoco Remedies Limited Announces Cessation of Divakar M. Gavaskar and Rajiv P. Kakodkar as Independent Directors, Effective Mach 31, 2024
Indoco Remedies Arm Begins Commercial Production from New Manufacturing Unit
Indoco Remedies to Buy Land in Mumbai for Expansion
Indoco Remedies Arm Begins Commercial Production at New Oral Care Unit
Indoco Remedies' Consolidated Profit Slumps in Fiscal Q3; Shares Drop 6%
Indoco Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Indoco Remedies Gets Establishment Inspection Report from US FDA after Goa Unit Inspection
Indoco Remedies Gets Tentative US FDA Nod for Generic Diabetes Drug
Indoco Remedies Receives Tentative ANDA Approval from USFDA for Canagliflozin Tablets
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action INDOCO
  4. Actualités Indoco Remedies Limited
  5. Autres langues